← Back to Search

Smartphone App for Cancer-Related Pain Management

N/A

Waitlist Available

Led By Andrea Enzinger, MD

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Current or previous diagnosis of advanced cancer

Age ≥ 21 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a smartphone app to help cancer patients manage pain and keep track of their medications.

Who is the study for?

This trial is for adults over 21 years old who have advanced cancer and are currently experiencing or have experienced cancer-related pain. It's not specified who can't join, but typically those with conditions that could interfere with the app usage or study participation would be excluded.

What is being tested?

The I-STAMP trial is testing a smartphone app designed to help people with cancer manage their pain better. The app also helps track medication use to see if it improves symptom management.

What are the potential side effects?

Since this trial involves using a smartphone app, there aren't direct medical side effects like you'd get from drugs. However, users might experience stress or frustration if they find the technology difficult to use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with advanced cancer.

Select...

I am 21 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

E-scale Acceptability

Usability

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: I-STAMP TestingExperimental Treatment1 Intervention

Study procedures will be conducted as follows: Activities 1-3: Data Collection for application development Activity 4: To be added with future amendment

0 / 2Eligibility criteria met